Sustained action formulation of cyclosporin form 2
US8785394B2 · kind B2 · utility
2Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 14, 2012 |
| Grant date | Jul 22, 2014 |
| Priority date | — |
| Expiry date | Nov 14, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K7/645
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are methods of treating diseases of the eye by administering to the subconjunctival space a formulation comprising cyclosporin A form 2 and a hydrogel.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.